Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1Classical hematology 1CNS 1

Conditions

Thrombocytopenia 1Oligodendroglioma 1Gliosarcoma 1Glioma 1Glioblastoma 1Ependymoma 1Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

eltrombopag 4Platelet Transfusion 4romiplostim 2Cytarabine 2Cyclophosphamide 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2sodium thiosulfate 1pegfilgrastim 1niraparib 1fludarabine 1etoposide phosphate 1Vorinostat 1Tranexamic Acid 1Temozolomide 1Stem Cell Transplantation 1Saline Solution 1Rituximab 1Radiotherapy 1Pharmacokinetics 1Hematopoietic Stem Cell Transplantation 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Comparative Genomic Hybridization 1Carboplatin 1Busulfan 1Aspirin 1Amplified Fragment Length Polymorphism Analysis 1Aminocaproic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Thrombocytopenia × Comparative Genomic Hybridization × Clear all
NCT00471653 2018-07-09

Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Terminated
10 enrolled
CNSClassical hematologySarcoma

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Thrombocytopenia, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡